Skip to main content
BIR Issuancesby BetterGov.phBeta
Official source
Browse issuances
Revenue Memorandum Circular · RMC

RMC No. 56-2022

To publish the March 16, 2022 FDA letter endorsing updates to the List of VAT-Exempt Medicines under Republic Act No. 11534 (CREATE Act).

Bureau of Internal RevenueIndependent research copy
Document type
RMC
Number
56
Year
2022
Text quality
Not specified

Document text

Reference copy · verify against the official source
RMC No. 56-2022, issued April 27, 2022, publishes a March 16, 2022 letter from FDA OIC-Director General Dr. Oscar G. Gutierrez Jr. endorsing updates to the List of VAT-Exempt Medicines under Republic Act No. 11534 (CREATE Act). Certain medicines for hypertension and COVID-19 treatment were added to the List, and corrections were made for several hypertension medicines. The specific medicines are not identified in the provided text.